ETFs positioned on RaySearch Laboratories AB

Name YTD change Weight AuM
+2.46%0.48% 31 M€
+5.24%0.3% 48 M€
+10.68%0.17% 679 M€
+10.83%0.1% 3,620 M€
+17.96%0.07% 1,260 M€
+7.76%0.05% 184 M€
+12.94%0.05% 918 M€
+12.25%0.05% 121 M€
+12.16%0.05% 241 M€
-9.32%0.05% 336 M€
+10.40%0.05% 336 M€
+9.61%0.04% 1,076 M€
+6.91%0.03% 429 M€
+19.01%0.02% 19,658 M€
+13.85%0.02% 5,871 M€
+11.54%0.02% 361 M€
-1.27%0.02% 7 M€
+11.57%0.02% 13,445 M€
+12.62%0.02% 258 M€
+14.25%0.01% 18,816 M€
+11.41%0.01% 692 M€
+8.84%0.01% 1,501 M€
+16.59%0.01% 13 M€
+17.06%0.01% 153 M€
+16.14%0.01% 8,963 M€
+17.53%0.01% 2,014 M€
+10.33%0.01% 9,367 M€
+1.57%0.01% 675 M€
+13.51%0.01% 16,918 M€
+12.64%0.01% 2,343 M€
+13.61%0% 8 M€
+11.18%0% 509 M€
+10.74%0% 219 M€
+12.09%0% 128 M€
+13.44%0% 1,439 M€
+9.91%0% 742 M€
+14.33%0% 231 M€
+12.55%0% 195,188 M€
+15.00%0% 8,229 M€
+10.51%0% 1,193 M€
+9.83%0% 888 M€
+10.01%0% 56 M€
+8.60%0% 317 M€
+14.49%0% 15,575 M€
0.00%0% 25 M€
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
181.20SEK
Average target price
297.50SEK
Spread / Average Target
+64.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock
  4. ETFs RaySearch Laboratories AB